132 related articles for article (PubMed ID: 24720773)
1. Platelet glycoprotein IIIa gene polymorphism (Leu33Pro) and aspirin resistance in a very elderly Chinese population.
Wang BY; Tan SJ
Genet Test Mol Biomarkers; 2014 Jun; 18(6):389-93. PubMed ID: 24720773
[TBL] [Abstract][Full Text] [Related]
2. The role of platelet glycoprotein IIIa polymorphism in the high prevalence of in vitro aspirin resistance in patients with intracoronary stent restenosis.
Pamukcu B; Oflaz H; Nisanci Y
Am Heart J; 2005 Apr; 149(4):675-80. PubMed ID: 15990752
[TBL] [Abstract][Full Text] [Related]
3. Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibalpha) polymorphisms.
Macchi L; Christiaens L; Brabant S; Sorel N; Ragot S; Allal J; Mauco G; Brizard A
J Am Coll Cardiol; 2003 Sep; 42(6):1115-9. PubMed ID: 13678940
[TBL] [Abstract][Full Text] [Related]
4. Association of the platelet membrane glycoprotein I a C807T gene polymorphism with aspirin resistance.
Su G; Wang Z; Ding Y
J Huazhong Univ Sci Technolog Med Sci; 2007 Dec; 27(6):664-7. PubMed ID: 18231737
[TBL] [Abstract][Full Text] [Related]
5. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
[TBL] [Abstract][Full Text] [Related]
6. PlA(1)/PlA(2) polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty.
Verdoia M; Pergolini P; Camaro C; Restifo M; Rolla R; Schaffer A; Di Giovine G; Marino P; Bellomo G; Suryapranata H; De Luca G;
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):411-8. PubMed ID: 23412353
[TBL] [Abstract][Full Text] [Related]
7. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action].
Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV
Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091
[TBL] [Abstract][Full Text] [Related]
8. Platelet GP IIIa Pl(A) polymorphisms display different sensitivities to agonists.
Michelson AD; Furman MI; Goldschmidt-Clermont P; Mascelli MA; Hendrix C; Coleman L; Hamlington J; Barnard MR; Kickler T; Christie DJ; Kundu S; Bray PF
Circulation; 2000 Mar; 101(9):1013-8. PubMed ID: 10704169
[TBL] [Abstract][Full Text] [Related]
9. Variable number of tandem repeats polymorphism of platelet glycoprotein Ib alpha in Chinese people and CC genotype with aspirin sensitivity in patients with cerebral infarction.
Jin YY; Yu GZ; Wang Y; Cui LY; Xin XM
J Clin Pharm Ther; 2009 Apr; 34(2):239-43. PubMed ID: 19250145
[TBL] [Abstract][Full Text] [Related]
10. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.
Dropinski J; Musial J; Jakiela B; Wegrzyn W; Sanak M; Szczeklik A
Thromb Haemost; 2005 Dec; 94(6):1300-5. PubMed ID: 16411409
[TBL] [Abstract][Full Text] [Related]
11. The contribution of platelet glycoproteins (GPIa C807T and GPIba C-5T) and cyclooxygenase 2 (COX-2G-765C) polymorphisms to platelet response in patients treated with aspirin.
Al-Azzam SI; Alzoubi KH; Khabour OF; Tawalbeh D; Al-Azzeh O
Gene; 2013 Sep; 526(2):118-21. PubMed ID: 23688555
[TBL] [Abstract][Full Text] [Related]
12. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
13. Increased platelet-monocyte aggregation in male claudicants with the Pl(A1/A2) polymorphism of Gp IIb/IIIa.
McCaslin J; Ashour H; Bhattacharya V; Cleanthis M; Daly A; Stansby G
Eur J Vasc Endovasc Surg; 2008 Aug; 36(2):132-137. PubMed ID: 18396070
[TBL] [Abstract][Full Text] [Related]
14. Does glycoprotein IIIa gene (Pl(A)) polymorphism influence clopidogrel resistance? : a study in older patients.
Papp E; Havasi V; Bene J; Komlosi K; Talian G; Feher G; Horvath B; Szapary L; Toth K; Melegh B
Drugs Aging; 2007; 24(4):345-50. PubMed ID: 17432927
[TBL] [Abstract][Full Text] [Related]
15. Association of CYP2C19, CYP3A5 and GPIIb/IIIa gene polymorphisms with Aspirin and Clopidogrel Resistance in a cohort of Indian patients with Coronary Artery Disease.
Arya V; Mahajan P; Saraf A; Mohanty A; Sawhney JP; Bhargava M
Int J Lab Hematol; 2015 Dec; 37(6):809-18. PubMed ID: 26264906
[TBL] [Abstract][Full Text] [Related]
16. Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke.
Carter AM; Catto AJ; Bamford JM; Grant PJ
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1124-31. PubMed ID: 9672073
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of the platelet receptors P2Y(12), P2Y(1) and GP IIIa and response to aspirin and clopidogrel.
Lev EI; Patel RT; Guthikonda S; Lopez D; Bray PF; Kleiman NS
Thromb Res; 2007; 119(3):355-60. PubMed ID: 16581111
[TBL] [Abstract][Full Text] [Related]
18. The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing.
Newman PJ; Derbes RS; Aster RH
J Clin Invest; 1989 May; 83(5):1778-81. PubMed ID: 2565345
[TBL] [Abstract][Full Text] [Related]
19. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa.
Szczeklik A; Undas A; Sanak M; Frolow M; Wegrzyn W
Br J Haematol; 2000 Sep; 110(4):965-7. PubMed ID: 11054089
[TBL] [Abstract][Full Text] [Related]
20. [Mean platelet volume: interactions with platelet aggregation activity and glycoprotein IIb-IIIa and Ib expression levels].
Khaspekova SG; Ziuriaev IT; Iakushkin VV; Naĭmushin IaA; Sirotkina OV; Zaĭtseva NO; Ruda MIa; Mazurov AV
Biomed Khim; 2014; 60(1):94-108. PubMed ID: 24749250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
